Legislation roundup: Data security, pharma antitrust and insurance investment in REITs

November 19, 2021 | BY

Susan Mok

Data processors may not take biometric features as the sole method of authenticating individuals' identities. Anti-monopoly guidelines are set forth regarding the active pharmaceutical ingredient sector. Insurance capital may invest in REITs.

Share:

Cybersecurity

Cyberspace Administration of China, Regulations for the Administration of Cyber Data Security (Draft for Comments)

国家互联网信息办公室网络数据安全管理条例 (征求意见稿)

Where a data processor is to provide data collected and generated in the People's